Mangmang Li
- Cancer Research top 10%
- Molecular Biology top 10%
- Bone Metabolism and Diseases 4
- PI3K/AKT/mTOR signaling in cancer 3
- CRISPR and Genetic Engineering 3
- Genomics and Chromatin Dynamics 3
- Pluripotent Stem Cells Research 3
- Epigenetics and DNA Methylation 3
- Oncology top 10%
- Biotechnology top 10%
- Transgenic Plants and Applications 4
-
- Plant Virus Research Studies 5
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Communications (1 paper)Blood (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Mangmang Li
38 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 169
- Molecular Biology 726
- Oncology 255
- Biotechnology 53
- Rheumatology 80
Countries citing papers authored by Mangmang Li
This map shows the geographic impact of Mangmang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mangmang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mangmang Li more than expected).
Fields of papers citing papers by Mangmang Li
This network shows the impact of papers produced by Mangmang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mangmang Li. The network helps show where Mangmang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mangmang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 12 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 35 | |
| 9 | 2019 | 25 | |
| 10 | 2019 | 17 | |
| 11 | 2018 | 12 | |
| 12 | 2018 | 44 | |
| 13 | 2016 | 11 | |
| 14 | 2015 | 4 | |
| 15 | 2015 | 79 | |
| 16 | 2012 | 215 | |
| 17 | 2012 | 9 | |
| 18 | 2010 | 5 | |
| 19 | 2006 | 6 | |
| 20 | 2005 | 36 |
About Mangmang Li
Mangmang Li is a scholar working on Developmental Neuroscience, Biotechnology and Electrochemistry, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Plant Virus Research Studies (5 papers), Transgenic Plants and Applications (4 papers), Bone Metabolism and Diseases (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), CRISPR and Genetic Engineering (3 papers), Genomics and Chromatin Dynamics (3 papers), Pluripotent Stem Cells Research (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (169 citations), Molecular Biology (726 citations) and Oncology (255 citations). Mangmang Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jing Huang, Xiaolin Wu, Wendy Dubois, Jianxin Shi, Yunlong He, Xiaochun Bai, Yu Jiang, Anling Liu, Daozhang Cai and Bin Huang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.